# Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

> **NCT06039176** · — · RECRUITING · sponsor: **International Consortium of Circulatory Assist Clinicians** · enrollment: 150 (estimated)

## Conditions studied

- LVAD
- Frailty
- GI Bleed
- Right Heart Failure
- Infections
- Hypertension
- Arrhythmias
- Stroke

## Interventions

- **DEVICE:** HeartMate 3 (R) left ventricular assist device

## Key facts

- **NCT ID:** NCT06039176
- **Lead sponsor:** International Consortium of Circulatory Assist Clinicians
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-27
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-12-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06039176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06039176, "Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06039176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*